IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ensysce Biosciences Inc (ENSC)

CUSIP: 293602504 | NYSE | Healthcare · Biotechnology | Micro Cap | 35 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ABob Gene Gower1,206,5766.1%New 5%+ stakeAug 7, 2026No 13F filer matched
13D/ABob Gene Gower1,206,576
6.1% of class · Aug 7, 2026

Institutional Holders — Q3 2026

StoneX Group Inc.138,563
0.0% of portfolio›$49.7K
Geode Capital Management, LLC61,862
0.0% of portfolio›$25.7K
FNY Investment Advisers, LLC3,000
0.0% of portfolio›$1
SBI Securities Co., Ltd.627
0.0% of portfolio›$261
Citigroup Inc456
0.0% of portfolio›$190
Ascentis Independent Advisors80
0.0% of portfolio›$33
StyleTurnoverLocationFiled
StoneX Group Inc.
138,563$49.7K0.0%ETFMediumNew York, NY2026-11-03
Geode Capital Management, LLC
61,862$25.7K0.0%IndexVery LowBoston, MA2026-11-06
FNY Investment Advisers, LLC
3,000$10.0%GrowthVery HighNew York, NY2026-10-16
SBI Securities Co., Ltd.
627$2610.0%GrowthLowTokyo, Mexico2026-10-22
Citigroup Inc
456$1900.0%CoreMediumNew York, NY2026-11-04
Ascentis Independent Advisors
80$330.0%GrowthLowDallas, TX2026-11-03
New 5%+ stake
No 13F filer matched